In diabetes with MAFLD, TNFRSF1A activation induces NF-kappa B translocation, resulting in the production of pro-inflammatory factors like IL-6 and TNF-α, which exacerbate liver inflammation. This evidence concerns the gene IL6 and diabetes mellitus.